The Arginine-16 Β2-Adrenoceptor Polymorphism Predisposes to Bronchoprotective Subsensitivity in Patients Treated With Formoterol and Salmeterol

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.2003.01955.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Evaluation of the Beta 2 Adrenoceptor Agonist/Antagonist Activity of Formoterol and Salmeterol.

Thorax
PulmonaryRespiratory Medicine
1996English

Add-On Therapy With Montelukast or Formoterol in Patients With the Glycine-16 Β2-Receptor Genotype

British Journal of Clinical Pharmacology
Pharmacology
2003English

Polymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results

ISRN Pulmonology
2013English

Subsensitivity to Bronchoprotection Against Adenosine Monophosphate Challenge Following Regular Once-Daily Formoterol

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1998English

Complex Formation Between VEGFR2 and the Β2-Adrenoceptor

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2019English

The P72R Polymorphism of P53 Predisposes to Obesity and Metabolic Dysfunction

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

Effects of Formoterol, Salmeterol or Oxitropium Bromide on Airway Responses to Salbutamol in COPD

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1998English

Β1- And Β2-Adrenoceptor Polymorphisms and Cardiovascular Diseases

British Journal of Pharmacology
Pharmacology
2009English

Intramuscular Administration of the Β2-Agonist, Formoterol, to Reduce Muscle Atrophy After Denervation

International Journal of Dentistry and Oral Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy